Product Information
ALA-HIST IR 2 MG TABLET is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6606 per EA under NDC 50991078360. Its NADAC has been published 510 times since Nov 28, 2013.
Strength
2 mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991078360
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXBROMPHENIRAMINE MALEATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/22/2011
Price Statistics
The NADAC for ALA-HIST IR 2 MG TABLET has been published 510 times since Nov 28, 2013, and over the history we have for it it has risen 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6606 per EA |
|---|---|
| All-time high | $0.6751 (Apr 11, 2018) |
| All-time low | $0.5829 (Nov 28, 2013) |
| 52-week high | $0.6612 |
| 52-week low | $0.6546 |
| Median price | $0.6176 |
| Average price | $0.6260 |
| Largest weekly change | +9.1% (Jan 17, 2018) |
| Weeks tracked | 510 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexbrompheniramine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexbrompheniramine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALA-HIST IR 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALA-HIST IR 2 MG TABLET, manufactured by Poly Pharmaceuticals, Inc., is $0.6606 per EA (NDC 50991078360), effective Sep 30, 2026.
How has the price of ALA-HIST IR 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALA-HIST IR 2 MG TABLET has risen 13.3%. It has been tracked across 510 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALA-HIST IR 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ALA-HIST IR 2 MG TABLET has ranged from a low of $0.5829 (Nov 28, 2013) to a high of $0.6751 (Apr 11, 2018), with a median of $0.6176 per EA.
Are there cheaper alternatives to ALA-HIST IR 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ALA-HIST IR 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALA-HIST IR 2 MG TABLET?
ALA-HIST IR 2 MG TABLET (NDC 50991078360) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.